BRD2 and cryohydrocytosis: However, in the case of the patient who developed cholecystitis, CHC levels decreased following treatment with cholecystectomy but remained elevated relative to baseline, perhaps reflecting the underlying primary tumor resistance to NAT (Figure 4).